These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10782755)

  • 1. Hyperuricaemia in Type 2 diabetes mellitus.
    Wun YT; Chan CS; Lui CS
    Diabetes Nutr Metab; 1999 Aug; 12(4):286-91. PubMed ID: 10782755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum uric acid and metabolic syndrome in type 2 diabetes.
    Bonakdaran S; Kharaqani B
    Curr Diabetes Rev; 2014 Mar; 10(2):113-7. PubMed ID: 24588601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of risk factors for uric acid nephrolithiasis in type 2 diabetes.
    Hari Kumar KV; Modi KD
    Saudi J Kidney Dis Transpl; 2011 May; 22(3):482-7. PubMed ID: 21566304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of hypertension and metabolic factors on the development of coronary heart disease in type II diabetic patients].
    Schmechel H; Schulze J; Hanefeld M; Julius U; Schwanebeck U; Lippold C
    Z Gesamte Inn Med; 1988 Dec; 43(23):669-74. PubMed ID: 3245248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid concentrations in type 2 diabetes: its significant relationship to serum 1,5-anhydroglucitol concentrations.
    Gotoh M; Li C; Yatoh M; Iguchi A; Hirooka Y
    Endocr Regul; 2005 Dec; 39(4):119-25. PubMed ID: 16552989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
    Bianchi C; Penno G; Malloggi L; Barontini R; Corfini M; Giovannitti MG; Di Cianni G; Del Prato S; Miccoli R
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):31-8. PubMed ID: 17420118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
    Huang JX; Liao YF; Li YM
    Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia and albuminuria in patients with type 2 diabetes mellitus.
    Bonakdaran S; Hami M; Shakeri MT
    Iran J Kidney Dis; 2011 Jan; 5(1):21-4. PubMed ID: 21189429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleeping disturbances and predictor risk factors among type 2 diabetic mellitus patients.
    Bener A; Al-Hamaq AOAA; Agan AF; Öztürk M; Ömer A
    Ann Afr Med; 2020; 19(4):230-236. PubMed ID: 33243945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of retinal nerve fibre layer and macular thickness with serum uric acid among type 2 diabetes mellitus.
    Vinuthinee-Naidu MN; Zunaina E; Azreen-Redzal A; Nyi-Nyi N
    BMC Ophthalmol; 2017 Jun; 17(1):91. PubMed ID: 28615022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of elevated serum uric acid with coronary heart disease in diabetes mellitus.
    Rathmann W; Hauner H; Dannehl K; Gries FA
    Diabete Metab; 1993; 19(1 Pt 2):159-66. PubMed ID: 8314420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
    Shahid SM; Nawab SN; Shaikh R; Mahboob T
    Pak J Pharm Sci; 2012 Jan; 25(1):123-9. PubMed ID: 22186319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid levels and the risk of type 2 diabetes: a prospective study.
    Bhole V; Choi JW; Kim SW; de Vera M; Choi H
    Am J Med; 2010 Oct; 123(10):957-61. PubMed ID: 20920699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated hemoglobin targets and glycemic control: Link with lipid, uric acid and kidney profile.
    Sunjaya AP; Sunjaya AF
    Diabetes Metab Syndr; 2018 Sep; 12(5):743-748. PubMed ID: 29709468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2005 Oct; 70(1):71-80. PubMed ID: 16126125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ramadan fasting on glycemic control and other essential variables in diabetic patients.
    Bener A; A Al-Hamaq AOA; Öztürk M; Çatan F; Haris PI; Rajput KU; Ömer A
    Ann Afr Med; 2018; 17(4):196-202. PubMed ID: 30588933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults.
    Li L; Song Q; Yang X
    J Diabetes Res; 2019; 2019():3175418. PubMed ID: 31871945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of micro- and macroalbuminuria in a Canarian population of type 2 diabetic patients. Relationship with blood pressure, lipid profile, obesity and metabolic control.
    De Pablos PL; Martinez J; Martinez MP; Doreste JA
    Diabetes Metab; 1998 Sep; 24(4):337-43. PubMed ID: 9805644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION AMONG TYPE 2 DIABETIC PATIENTS AT MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA.
    Ndege BW; Diero LO; Owiti MO; Anjichi G; Siika AM
    East Afr Med J; 2014 Aug; 91(8):253-60. PubMed ID: 26862649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.